Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Northwest Biotherapeutics, Inc. (NWBO) had Book Value Per Share of $-0.02 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.81M |
|
$-9.55M |
|
-- |
|
$0.81M |
|
$12.41M |
|
$-11.61M |
|
$2.38M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-9.22M |
|
$-11.61M |
|
$-10.71M |
|
1.64B |
|
1.64B |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$2.57M |
|
$16.48M |
|
$73.37M |
|
$75.94M |
|
$73.35M |
|
$6.21M |
|
$37.37M |
|
$110.72M |
|
$-45.17M |
|
$-87.33M |
|
$-34.78M |
|
1.67B |
|
| Cash Flow Statement Financials | |
$-19.68M |
|
$-0.33M |
|
$16.58M |
|
$3.04M |
|
$0.59M |
|
$-2.44M |
|
$0.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.22 |
|
-1.14 |
|
100.00% |
|
-1438.04% |
|
-1438.04% |
|
-- |
|
-1142.63% |
|
-1183.77% |
|
$-20.00M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
20.41% |
|
10.56% |
|
-12.14% |
|
32.28% |
|
|
Book Value Per Share |
$-0.02 |
$-0.01 |
|
$-0.01 |
|